A Single-Arm, Multicenter Phase IIa Study Of rhLTα-Da In Combination With Cisplatin And Fluorouracil As A First-Line Therapy For The Treatment Of Patients With Metastatic Oesophageal Squamous Cell Carcinoma Or Gastric Adenocarcinoma

Trial Profile

A Single-Arm, Multicenter Phase IIa Study Of rhLTα-Da In Combination With Cisplatin And Fluorouracil As A First-Line Therapy For The Treatment Of Patients With Metastatic Oesophageal Squamous Cell Carcinoma Or Gastric Adenocarcinoma

Completed
Phase of Trial: Phase II

Latest Information Update: 16 May 2017

At a glance

  • Drugs Cisplatin (Primary) ; Fluorouracil (Primary) ; Lymphotoxin alpha (Primary)
  • Indications Adenocarcinoma; Gastric cancer; Oesophageal cancer; Squamous cell cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 16 May 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top